TROP-2 was expressed at significantly higher levels in ATC undifferentiated from papillary thyroid carcinoma than in ATC undifferentiated from follicular thyroid carcinoma and de novo ATC. This evidence concerns the gene TACSTD2 and thyroid gland follicular carcinoma.